# OnCo record medicare-ncd-110-18 (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/medicare-ncd-110-18/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "medicare-ncd-110-18" ;
  schema:name "Medicare NCD 110.18: aprepitant for chemotherapy-induced vomiting"@en ;
  schema:alternateName "NCD 110.18"@en, "Aprepitant for Chemotherapy-Induced Emesis"@en, "Medicare oral antiemetic coverage"@en ;
  schema:description "Medicare Part B pays for an all-oral three-drug anti-sickness regimen, aprepitant with a 5-HT3 blocker and dexamethasone, for people receiving one of 20 listed chemotherapy drugs. It does not pay for aprepitant on its own."@en ;
  schema:url <https://onco.cc/terms/medicare-ncd-110-18/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?ncdid=309&ncdver=2>, <https://api.coverage.cms.gov/v1/data/ncd?ncdid=309&ncdver=2> ;
  onco:tag "us" ;
  onco:technologies <https://onco.cc/technologies/antiemetic-therapy/> ;
  onco:drugs <https://onco.cc/drugs/aprepitant/>, <https://onco.cc/drugs/dexamethasone/>, <https://onco.cc/drugs/ondansetron/> ;
  onco:institutions <https://onco.cc/institutions/cms/>, <https://onco.cc/institutions/nccn-org/>, <https://onco.cc/institutions/asco/>, <https://onco.cc/institutions/esmo/>, <https://onco.cc/institutions/mascc/> .